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Intercellular signaling events mediated by neuropeptides and peptide hormones represent
important targets for both basic science and drug discovery. For many bioactive peptides,
the protein receptors that transmit information across the receiving cell membrane are not
known, severely limiting these signaling pathways as potential therapeutic targets. Identifying
the receptor(s) for a given peptide of interest is complicated by several factors. Most notably,
cell-cell signaling peptides are generated through dynamic biosynthetic pathways, can act on many
different families of receptor proteins, and can participate in complex ligand-receptor interactions
that extend beyond a simple one-to-one archetype. Here, we discuss recent methodological
advances to identify signaling partners for bioactive peptides. Recent advancements have centered
on methods to identify candidate receptors via transcript expression, methods to match peptide
receptor pairs through high throughput screening, and methods to capture direct ligand-receptor
interactions using chemical probes. Future applications of the receptor identification approaches
discussed here, as well as technical advancements to address their limitations, promises to lead to
a greater understanding of how cells communicate to deliver complex physiologies. Importantly,
such advancements will likely provide novel targets for treatment of a number of human diseases
within the central nervous and endocrine systems.
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Introduction
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Neuropeptides and peptide hormones are cell-to-cell signaling molecules abundant in the
central nervous system (CNS) and endocrine system, where they act as key modulators
of physiological processes such as body temperature,1, 2 energy homeostasis,3 circadian
rhythm,4 and more.5 Mimicking or antagonizing peptide signaling represents a potential
strategy for treating a number of human diseases, including epilepsy,6 depression,7, 8
diabetes,9 osteoporosis,10 and others.11, 12 Advances in mass spectrometry (MS)-based
“peptidomics” methodologies has enabled the confident identification of a large number
of endogenous peptides that correlate or appear to directly regulate normal physiology
or disease states.13–15 However, for many functional peptides discovered, the receptor
protein(s) responsible for transmitting their signals are not known.16–27 A lack of validated
receptors for bioactive peptides severely limits the ability to rationally design drug
molecules targeting these pathways.

Author Manuscript

The purpose of this review is to discuss two subjects critical to identify the receptor
proteins for a given bioactive peptide. First, we outline some of the challenges associated
with determining receptors for cell-cell signaling peptides, including those arising from
their unique biosynthesis and complicated ligand-receptor interactions. We highlight that
peptide-receptor interactions are often much more complex than a simple one peptide-one
receptor paradigm, and that peptides may activate a number of classes of receptor other
than “orphan” G protein-coupled receptors (GPCRs). These possibilities make identifying
the receptor for a given peptide fundamentally distinct from research efforts that aim
to “deorphanize” GPCRs.28 Second, we provide an overview of recent methodological
advances that have proven successful for identifying functional receptors for peptides of
interest. Although this review focuses on endogenous cell-cell signaling peptides, many of
the approaches described can also be applied to other ligands without known receptors, such
as natural products or toxins. Recent progress and future work identifying receptors for
bioactive peptides promises to open up new avenues of exploration in understanding normal
cellular communication and in treating diseases caused by signal dysregulation.

Neuropeptide and peptide hormone discovery

Author Manuscript

Both neuropeptides and peptide hormones are generally synthesized from larger precursor
peptides that undergo extensive post-translational modifications (Figure 1). In most cases,
an amino acid sequence (termed a “signal sequence”) in the precursor targets the newly
translated protein to the secretory pathway, where it is transported via secretory granules
to the point of release on the outer membrane. Beginning during translation and continuing
during trafficking, propeptides undergo a series of proteolytic processing steps to generate
several smaller peptides, which generally involves cleavage at dibasic (e.g., KK, KR, etc.)
or monobasic sites by endopeptidases (e.g., PC1/3, PC2)29, 30 followed by subsequent
“trimming” by exopeptidases (e.g., carboxypeptidase E).31, 32 In addition to these well
established processing pathways, enzymes such as furin,33–35 carboxypeptidase D,36 and
cathepsins L, V, and H,13, 37–39 may also be involved in processing a subset of peptides,
although the full roles of these enzymes in neuropeptide and peptide hormone processing
remain unclear and warrant further study. Full maturation of cell-cell signaling peptides
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can also include side-chain and backbone modifications, including C-terminal amidation,40
terminal and side-chain acylation,41, 42 phosphorylation,43 sulfation,43–45 glycosylation,46
and others.13, 47–49 These post-translational modifications (PTMs) are often essential for the
known functions of the mature peptides; deficiency in enzymes responsible for these PTMs
often produce severe phenotypes50, 51 and exogenous administration of synthetic peptides
lacking such PTMs often have significantly reduced biological activity.41, 52, 53

Author Manuscript
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The biosynthetic pathway common to most cell-cell signaling peptides leads to a number
of important consequences that set these molecules apart from many other proteins.
First, a given precursor often generates a number of unique mature peptides, many
of which can have distinct functions.5, 13 Furthermore, precursor processing can differ
significantly between tissues or across different physiological states. For example, the
proopioimelanocortin (POMC) precursor is processed into over 10 distinct peptides in
the pituitary, and the peptides produced differ significantly between the anterior and
intermediate lobes.42, 54 The peptides produced from this differential processing then
proceed to act on distinct subsets of receptors, ultimately leading to different physiological
functions.54 Similarly, proglucagon generates a number of distinct peptides in a tissue
dependent manner, including glucagon and glucagon-like peptide 1 (GLP-1), and these
peptides activate distinct receptors.55 Bioactive peptides can also be generated through
pathways outside of the canonical secretory pathway, such as the hemorphins and
hemopressins (generated from proteolytic cleavage of hemoglobin).56, 57 As another
example of non-canonical signaling peptides, small open reading frames (smORFs) generate
bioactive peptides through mechanisms distinct from secreted peptides,20, 21 and can play
roles in cell-cell signaling.58 However, because of their small size (<100 codons), smORFs
are usually excluded from gene annotations and smORF-encoded peptides often evade
detection in standard proteomic searches, suggesting that the majority of smORF-encoded
peptides have yet to be fully characterized. As a result of the complexity of biosynthesis
and post-translational processing, mature peptide products generated from a given tissue can
rarely be predicted based on genome or transcript information alone, but instead must be
characterized using techniques that can directly measure a peptide’s final form, including all
PTMs.

Author Manuscript

Mass spectrometry is currently the most comprehensive tool employed to identify
and characterize peptide signaling molecules.13–15 Importantly, MS-based peptidomics
analysis allows for the non-targeted identification of peptides from biological tissues,
and the high resolving power of modern mass spectrometers allows for determination
of precise sequence composition, including nearly all post-translational modifications.
Most peptidomics workflows utilize computational algorithms to match experimental
MS and MS/MS data to predicted spectra generated from genome- or transcriptome
derived protein databases, a method termed “probability sequence matching”.14 However,
probability sequence matching requires a well curated and accurate protein database with
which to generate the predicted peptide fragmentation spectra, and is unable to identify
peptide matches not present in the database (including mutations). A distinct peptide
sequencing approach, de novo sequencing, generates experimental sequence tags directly
from experimental MS and MS/MS data, and then queries these tags against the target
protein database.14, 59, 60 Because de novo sequencing first generates peptide sequences
ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.
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based solely on the experimental data, this method allows the identification of peptides
not present in the search databases, including mutations and errors in the deposited protein
sequences. Advances in sampling have enabled characterization of peptides within specific
tissues,61–63 released from tissues into extracellular space,4, 64 from an individual cell,65, 66
and even within individual organelles.67 Thus, the technical advancements in measurement
science coupled to bioinformatics have enabled the identification and quantification of a
large number of endogenous peptides from a wide array of organisms and tissues. Because
these advancements in peptide identification tend to detect peptides based on abundance
rather than specific functions, many peptides discovered through peptidomics approaches do
not have well-understood biological activity at the time of their discovery.16, 21 One of many
key pieces of information that contributes to a full understanding of a cell-cell signaling
peptide’s biological function is insight into what receptor proteins are engaged and activated
to transmit signals. However, identifying receptor proteins for a given endogenous peptide is
often complicated by several factors arising from the biology of these molecules.

Challenges in neuropeptide and hormone receptor identification
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The unique biosynthetic, structural, and functional properties of precursor-derived peptides
offer a number of challenges for identifying receptor proteins that differ from those of
many other classes of protein-protein interactions. For one, a single precursor often gives
rise to many different peptide sequences (distinct peptides and alternatively processed
forms), which can have distinct biological functions and receptor specificities (Figure 1).
For many precursors, there is a bias by researchers to focus on one or two peptides with
very obvious bioactivity, while other peptides generated from the precursors are considered
byproducts from biosynthesis or completely ignored. However, these understudied peptides
may prove to play important roles in cell-cell signaling. For example, research on
proenkephalin-A has focused primarily on Met-enkephalin and Leu-enkephalin, potent
opioid peptides that are agonists of the δ-opioid receptor (δOR). Over 30 years after
the discovery of Met-enkephalin and Leu-enkephalin,68 proenkephalin-A-derived bovine
adrenal medulla peptide 22 (BAM22) was found to be a potent agonist for previously
orphan receptors in the Mas-related GPCR family termed “sensory neuron-specific GPCRs”
(SNSRs), which are localized to sensory neurons in the dorsal root ganglia and are
potential targets for the treatment of chronic pain.69–71 Interestingly, BAM22 has also
been shown to interact with SNSR-δOR heterooligomers to activate SNSR signaling while
simultaneously inhibiting δOR signaling,72 despite this peptide being a potent δOR agonist
when this receptor is expressed alone.69 In addition, not every peptide produced from a
given precursor is expected to signal through a canonical ligand-receptor interaction, and
some may serve alternative functions. As some examples, the C peptide from proinsulin
is well-known to play a critical role in insulin folding,73 and the peptide opiorphin’s
primary role is suspected to be as a protease inhibitor.16, 74 Nevertheless, a number of
well-studied precursors produce peptides which appear to have biological activity, but for
which no receptor has been unambiguously identified, including several peptides from the
proSAAS precursor,16 cerebellin peptide,17–19 several granin-derived peptides,22 glicentin
related pancreatic polypeptide,23 synenkephalin,24 GnRH-associated peptide 1,25 N-terminal
POMC peptides,26 and others.16, 27
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In addition to the fact that precursors often generate many peptides, neuropeptide and
peptide hormone signaling is complicated by complex peptide-receptor dynamics (Figure
2). Although some peptide-receptor systems adhere to a simple one peptide-to-one receptor
paradigm, most families feature multiple discrete ligands and several distinct receptors,
each with specific selectivities and biological functions. A recent analysis of known human
peptide-GPCR interactions found that each receptor responds to an average of 2.9 peptide
ligands, while each peptide was able to activate an average of 1.9 receptors.75 For example,
POMC generates several distinct peptides, including adrenocorticotropic hormone (ACTH),
β-lipotropin (LPH), γ-LPH, α-melanocyte stimulating hormone (MSH), β-MSH, γ-MSH,
β-endorphin, and several additional peptides with less well-defined functions.42 ACTH and
the MSH peptides can activate five different melanocortin receptors (MCRs), with each of
these receptors having distinct selectivities for each peptide, while β-endorphin potently
activates both the μ-opioid receptor and the δ-opioid receptor. An individual peptide can
also engage multiple unrelated receptors. For example, the peptide hormone relaxin-3, which
was initially identified as a ligand for the receptor LGR7,76 was also found to interact
with additional receptors GPCR135 and GPCR142 (now called RXFP3 and RXFP4).77, 78
Similarly, several opioid peptides have recently been demonstrated to interact with both
the opioid receptor family (κ, δ, and μ)79, 80 and the atypical chemokine receptor ACKR3/
CXCR7.81, 82 A single receptor can also engage multiple peptides from distinct precursors.
For example, the parathyroid hormone receptor 1 (PTHR1) is potently activated by peptide
ligands generated from distinct precursors (parathyroid hormone and parathyroid hormone
related protein), and these ligands interact and induce different conformations of the receptor
to enact distinct functions.83 Similarly, the Drosophilia sex peptide receptor is activated by
peptides from two distinct families.84 The complexity of neuropeptide and peptide hormone
signaling strongly suggests that for some known and well-studied peptides and receptors,
there may be additional interactions waiting to be discovered.

Only orphan GPCRs?

Author Manuscript

To identify the receptor for a given biologically active peptide, a common assumption is
that the peptide must act through an “orphan” GPCR, a term denoting the over 100 GPCRs
that do not have known endogenous ligands.16 This assumption is rooted in the notion that
signaling systems follow a one ligand-to-one receptor rule, and thus a peptide of interest is
likely to signal through a receptor that currently has no clearly identified ligand. However, as
outlined above, there are many examples in which a given receptor engages several peptides
from diverse precursors, indicating that even well-studied (non-orphan) receptors may
recognize additional ligands not yet characterized. As a result, a given peptide of interest
may signal through non-orphan receptors (Figure 3). Limiting a search to exclusively orphan
receptors risks overlooking important interactions with established receptors which may be
critical for biological function.
Another potential weakness in targeting exclusively orphan GPCRs for receptor
identification is the assumption that peptides only interact through proteins in the GPCR
family, and not with other families of membrane-bound receptors. Precursor-derived
peptides can signal through a variety of different proteins that are not members of the GPCR
family. For example, big-dynorphin (one of several peptides produced from prodynorphin)
ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.
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is a highly potent modulator of the acid-sensing ion channel ASIC1a, in addition to the
κ-opioid receptor.79, 85 Consistent with this observation, secreted peptides have been shown
to be direct modulators of receptors other than GPCRs, including ion channels,86–89 receptor
tyrosine kinases,90 receptor guanylyl cyclases,91, 92 and others.93–95
For many approaches to identify receptors for a given peptide, it is practical to use various
criteria to narrow down candidate receptors, and examining only orphan GPCRs is a
common strategy to generate this “short list”. Although there have been successes focusing
exclusively on orphan GPCRs (some of which are discussed in this review), this strategy
may miss physiologically important interactions. As new approaches to identify receptors
for peptides are developed, methods should strive to remain relatively unbiased and actively
explore many different classes of receptor proteins, both “well-studied” and “orphan”.
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Identifying receptor candidates based on expression
When faced with a specific peptide of interest without a known receptor, a careful
examination of gene expression between cell lines and tissues can be used to identify
receptor candidates (Figure 4). For this approach, several cell lines or tissues that show
response to the peptide (e.g., cAMP accumulation, Ca2+ influx, etc.) are collected and the
mRNA expression for potential receptors compared. Receptors that are expressed in all
reactive cells/tissues are then tested individually (usually in cell-based receptor activation
assays) to determine if the candidate receptor is responsible for the signaling event.
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Two important examples of using gene expression to guide receptor identification approach
involve the identification of receptors for proSAAS-derived peptides PEN and BigLEN.96, 97
PEN and BigLEN are highly abundant peptides found in the hypothalamus with proposed
roles in feeding regulation and metabolism. For each of these peptides, ligand binding and
ligand-induced cell signaling experiments suggested receptors present on both the Neuro2A
neuroblastoma cell line and on hypothalamic membranes. The signaling behavior in both
the cell line and tissue were consistent with activation of a GPCR. The researchers then
compared a list of orphan GPCRs enriched in both Neuro2A and in hypothalamus to
generate a candidate list of receptors. For BigLEN,96 four candidate GPCRs were each
recombinantly expressed in Chinese hamster ovary (CHO) cells along with a promiscuous
Gα subunit and individually tested for activation by exogenous BigLEN. Of the four
receptors tested, GPR171 showed a response consistent with agonism by BigLEN. The three
other candidate GPCRs evaluated showed no such activity from BigLEN, highlighting the
specificity of this identified interaction. Follow up experiments in this recombinant system,
as well as in cell lines and animals expressing endogenous receptor, demonstrate GPR171
plays a major role in biological function BigLEN, including feeding behavior in vivo.
For PEN,97 five candidate receptors were identified and evaluated using the same process
as described for BigLEN, and only one receptor (GPR83) was activated by exogenous
PEN peptide. It is important to note that despite BigLEN and PEN arising from the same
precursor these two peptides were found to activate distinct receptors, again highlighting
the complexity of neuropeptide signaling. Interestingly, follow-up experiments demonstrated
that GPR171 and GPR83 can interact and influence each other’s signaling,97 and these
interactions may differ between tissues.
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More recently, an expression-based approach was used to identify a receptor for maturation
inducing hormones (MIHs) in the jellyfish Clytia hemispherica responsible for oocyte
maturation.98 In this study, the researchers focused their search for MIH receptors on
GPCRs due to prior evidence showing an increase in cAMP concentration upon MIH
stimulation, consistent with signaling through a Gαs-mediated pathway. To identify potential
MIH receptor candidates, these researchers first generated a list of all predicted GPCRs
in this organism and then selected their candidate receptors from Class A GPCRs with
transcripts enriched in oocytes. From this analysis, 16 candidate GPCRs were individually
expressed in CHO cells along with a promiscuous Gα protein subunit and tested for
activation by a mixture of 33 predicted Clytia neuropeptides, including four MIHs. Of the 16
receptors tested, only one receptor (designated MIHR) was activated by the peptide mixture,
and subsequent experiments demonstrated that this receptor was specifically activated
by the four MIH peptides. Experiments utilizing MIHR knock-out jellyfish generated
from CRISPR/CAS9 revealed critical roles for both MIHR and MIH peptides in oocyte
maturation, consistent with the finding of MIHR as a critical MIH receptor.
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Similar to the approaches described above to identify the receptors for PEN, BigLEN,
and MIHs, an approach termed a “deductive ligand-receptor matching strategy” has been
used to identify potential receptors for several peptides based on gene expression across
cell types.99–103 Using PCR, the mRNA levels for orphan GPCRs are evaluated across
several cell lines and tissues responsive to stimulation by the peptide of interest. Receptors
which show mRNA expression in all responsive cell lines are then identified as initial
candidates, and a further curated to generate a “short list” based on criteria such as sequence
homology and tissue distribution. To evaluate candidate receptors, researchers employing
this technique generally utilize siRNA-mediated knockdown of each candidate receptor,
monitoring peptide-induced downstream signal. Using this approach, putative receptors have
been identified for neuronostatin (derived from the somatostatin precursor),99 the insulin
C peptide,100 phoenixin,101 adropin,102 and CART(55–102)/CART(65–102).103 However,
initial studies employing this deductive ligand-receptor matching approach often monitor
signaling events that are significantly downstream from the ligand receptor interaction, such
as changes in cFos mRNA expression,99, 102, 103 changes in ERK phosphorylation,103 and
in vivo effects.99–103 Furthermore, these initial studies rarely recombinantly express their
candidate receptors in non-responsive cell lines to provide “gain-of-function” activity to
peptide stimulation, as was performed in the PEN, BigLEN, and MIH examples described
above. Due to these limitations, it is more difficult to determine if responses using this
deductive ligand-receptor matching strategy are due to direct ligand-receptor interactions,
or if the identified proteins influence the observed signaling indirectly through alternative
mechanisms. In one case, follow-up studies using recombinant receptor provide conflicting
data for a ligand-receptor pair identified through a primarily siRNA-based strategy (adropin
with GPR19). Although Rao and Herr reported a adropin-mediated reduction of cAMP in
HEK293 cells expressing GPR19,104 Foster et al. report no activity for this ligand-receptor
pair by dynamic mass redistribution or internalization assays using Flp-In T-Rex 293 cells
expressing recombinant GPR19.75 Although the origin of this discrepancy is unclear, this
may suggest that the adropin-GPR19 interaction is more complex than a one-to-one peptide
receptor interaction. In some instances, follow-up studies demonstrating co-localization by
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microscopy103, 105 or co-immunoprecipitation experiments103 provide some evidence of a
peptide-receptor interaction. However, in many cases further studies must be performed
to more definitively validate putative peptide-receptor interactions identified using the
deductive ligand-receptor matching strategy.
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As described in the examples above, examining mRNA expression across cells and tissues
has proven successful to identify receptors for specific peptides of interest. In contrast to
high-throughput methods, the approaches discussed in this section tend to focus on one
peptide ligand of interest, allowing for more careful follow-up studies to validate the ligand
receptor hit and examine its effects in vivo. Although in theory examining gene expression
could be a non-targeted method to identify candidates, in practice researchers have generally
limited their candidate receptors to orphan GPCRs when generating short lists to evaluate
experimentally. As a result, any interactions between peptides of interest and non-orphan
receptors (or receptors of other classes) will not be detected using these strategies.

Large-scale screening approaches
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In principle, one method to identify a receptor for a given peptide would be to individually
express every possible receptor protein and test for activation. In the spirit of this approach,
high-throughput cellular screens have been developed to survey a large array of GPCRs
for activation by a given peptide or collections of peptides (Figure 5). As one prominent
example, a large-scale Tango β-arrestin recruitment assay was developed that facilitates the
simultaneous screening of a compound of interest against over 300 GPCRs.106 Advantages
of this powerful platform include the ability to screen both orphan and non-orphan GPCRs,
capability to screen for antagonists (if agonists are known), and open-access availability
to the scientific community. However, this platform screens against GPCRs exclusively,
so ligand interactions with non-GPCR proteins will be missed. In addition, any signaling
systems that require co-receptors for function, such as the receptor activity modifying
proteins,107 would likely not be functionally active in this panel. Finally, it is important to
note that over 50% of the GPCRs present in the panel (including all orphan GPCRs) were
not able to be functionally validated.106 Although a lack of validation does not necessarily
preclude identification of putative agonists for these receptors, it does increase the likelihood
of false negatives if using the platform to identify a receptor for a peptide of interest.
Complementary to the individual expression approach, genetic knock-out screens can also
identify novel ligand-receptor interactions by looking for loss of function upon ligand
stimulation.108, 109 However, knock-out screens can suffer from limitations, including a
dependency on endogenous receptor expression in the host cell line and inability to identify
receptors with functional redundancy. Although fully comprehensive screens are powerful,
in practice it is not possible to test every possible ligand with every possible receptor.
An alternative to a truly comprehensive high-throughput screen is to use some criterion to
preselect pools of candidate peptides and receptors for screening.
Invertebrates such as are Platynereis dumerilii are important systems to understand
neurotransmission and its influence on behavior, as well as the evolution of cell-cell
signaling systems.87, 110, 111 However, very few neuropeptide receptors have been identified
in non-model organisms, limiting the utility of homology searching as a means to

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 9

Author Manuscript
Author Manuscript

identify receptors for given peptides of interest. To overcome this limitation, Bauknecht
and Jékely recently employed a novel combinatorial strategy to match peptides with
putative neuropeptide GPCRs.110 In this approach, 87 predicted Platynereis GPCRs were
individually expressed in CHO cells along with a promiscuous Gα protein (to facilitate
signaling through the phospholipase C pathway) and exposed to each of three synthetic
peptide mixtures containing 32–48 predicted neuropeptides from Platynereis. For a given
expressed receptor, an increase in intracellular calcium concentration in response to one
of the three peptide mixtures suggested that an agonist was present in that mixture.
Receptors showing hits in this initial screen were further subjected to peptide sub-mixtures
to facilitate identification of the agonist peptide(s). Using this approach, these researchers
identified 19 novel ligand-receptor pairs, as well as several additional pairs predicted
based on orthology. Many of identified peptide-receptor pairings were not related to
known peptide/receptor families, highlighting the importance of pursuing a relatively
unbiased approach. Using a combinatorial screening strategy, these researchers were able
to evaluate 10,962 peptide-receptor combinations without testing each pair individually.
Similar strategies have subsequently been used to identify peptide-receptor pairs in other
non-model organisms.112, 113
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Computational approaches can also provide valuable insight to identify putative
neuropeptides and receptors prior to combinatorial screening. Foster et al. employed
bioinformatics methods to predict candidate neuropeptides and receptors by taking
advantage of common sequence motifs present in both.75 Candidate peptide ligands were
predicted from mining genomic information for specific sequence motifs (e.g., secretion
signal sequences and dibasic sites) and evolutionary conservation, while candidate peptide
receptors were predicted based on examining conserved sequence or structural motifs.
Constructs encoding for putative peptide receptors were expressed in mammalian cell
lines and evaluated for peptide ligand interactions using several different techniques. In
total, 218 predicted peptides were screened against 21 predicted peptide receptors (in
addition to known peptide receptors) and assayed for multiple signaling pathways associated
with ligand binding or stimulation: mass redistribution, receptor internalization, β-arrestin
recruitment, and second messenger stimulation. From these assays, peptide-mediated
responses were identified for all 21 predicted peptide receptors, demonstrating the utility
of this bioinformatics approach to accurately predict cell-cell signaling peptides and peptide
receptors. Interestingly, some signals were only seen in a subset of assay platforms (e.g.,
mass redistribution and receptor internalization but not β-arrestin recruitment), highlighting
the importance of screening multiple pathways in these types of studies. In addition, this
study identified 9 new peptides (and several known peptides) that activate multiple receptors,
again emphasizing the complexity of peptide-receptor interaction networks.
Combining machine learning with experimental validation can be an effective approach to
identify receptors for novel peptides. Shiraishi et al. recently demonstrated that machine
learning could predict novel peptide-receptor pairs even for ligand sequences that share
no sequence homology with known neuropeptides.114 In this study, these authors aimed
to identify receptors for neuropeptides from the invertebrate chordate Ciona intestinalis,
an important organism for the study of neuropeptide evolution in both invertebrates
and vertebrates. In addition to homologs of vertebrate neuropeptides, this animal also
ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.
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produces many Ciona-specific neuropeptides that share no sequence homology to known
peptides. While some neuropeptide-receptor pairs in this animal have been identified
based on sequence homology, this strategy is not possible for the Ciona-specific peptides.
To develop a machine-learning approach to identify novel peptide-receptor pairs, novel
Peptide Descriptors (derived from amino acid physiochemical properties) were developed
and incorporated into a support vector machine with known active and inactive ligand
receptor pairs as a training set. Prediction performance in this model was improved over
conventional machine-learning approaches by incorporating a novel genetic algorithm-based
feature selection. The optimized method was used to computationally screen interactions
between 140 putative GPCRs with 19 known neuropeptides, resulting in 29 predicted
peptide-receptor pairs. Predicted ligand-receptor pairs were then evaluated using Ca2+
mobilization assays. Overall, 12 peptide-receptor pairs were validated, representing a 41%
success rate for this approach. Importantly, 11 of the 12 identified pairs are non-homologous
to previously identified peptide-GPCR interactions.
One major advantage of large-scale cell-based screening approaches is their ability to
experimentally screen many individual ligand-receptor interactions for specific downstream
responses of interest, which can minimize false-positives from non-specific interactions that
may be detected in affinity-based approaches. In addition, application of genetic knockouts
or advances in machine learning can allow one to evaluate ligand-receptor interactions
without prior knowledge of receptor class. However, many screening approaches require
the assembly of large libraries of genetically manipulated cell lines, which can be time
consuming and difficult to validate.

Chemical capture-based approaches
Author Manuscript

The membrane-bound nature of the majority of cell-surface receptors presents technical
challenges for classical affinity-driven approaches to identify protein-protein interactions.
For neuropeptides and peptide hormones, these challenges are often exacerbated due
to the fact that peptide receptors often lack large extracellular domains (severely
limiting commonly used approaches involving recombinant protein libraries of receptor
ectodomains108) and are present at very low abundances. Peptide residence time at ligand
binding sites can also vary considerably between systems,115 which may limit traditional
pull-down approaches to characterize protein interaction networks.
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Despite the technical challenge, classic affinity-enrichment approaches, often with covalent
crosslinking, have been utilized to isolate receptors for peptide ligands. For example, early
studies to elucidate the receptors for vasoactive intestinal polypeptide116 and calcitonin
gene-related peptide117 made use of chemical crosslinking and enrichment to aid in
characterizing peptide receptors and associated proteins. However, correctly identifying
the sequences of these receptors was difficult based on crosslinking and pull-down alone,
and often was accomplished using gene expression-based approaches.118 Advancements
in protein sequencing by mass spectrometry have offered increased ability to determine
the primary sequence of receptors directly after pull-down. For example, photoreactive
crosslinking, protein isolation, and identification by MS identified an Arabidopsis leucine
rich repeat receptor kinase called PEPR1 as the receptor for the endogenous peptide AtPep1,
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which triggers activation of the plant’s innate immune response.119 Despite progress in this
methodology to identify novel peptide-receptor interactions,120 some disadvantages include
non-selectivity of photoreactive groups toward residues on the receptor protein and with
off-target proteins, high background labeling,121 short half-lives of reactive groups,122 and
inherently short reactive interaction window.123
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Proximity-induced reactivity offers an alternative to the highly reactive and transient
activation window of photoreactive groups. Proximity-induced approaches employ
functionalities with significantly reduced reactivity relative to traditional crosslinking
approaches, and rely on protein binding by the ligand to bring these reactive groups
into close proximity to protein for covalent bond formation.124 Perhaps one of the most
notable of these approaches for labeling and identifying extracellular peptide receptors
involves proximity-induced covalent bond formation between ligands labeled with hydrazine
derivatives and oxidized glycan functionalities on carbohydrate-containing receptors (Figure
6).125 After covalent bond formation on living cells, azide-alkyne cycloaddition facilitates
biotinylation of the peptide-receptor complex. Biotin then allows for the enrichment of
labeled proteins, which are then identified via MS analysis. Early examples of this
technology demonstrated its effectiveness to identify receptors for transferrin, apelin, growth
factors, insulin, and others as model ligands.125 Since its initial discovery, this technology
has been used to identify a number of peptide-receptor interactions, including identifying
LINGO2 as a primary receptor for the secreted cytokine Trefoil factor family 3 (TFF3)
involved in gastrointestinal wound healing,126 identifying thrombospondin 4 as a major
interaction partner for a serum peptide derived from high-molecular-weight kininogen
involved in regulating immune cell chemotaxis,127 and more.128–132 Recently, this ligand
receptor capture approach has been further developed and refined to overcome some prior
limitations.133, 134 It is important to note that the hydrazine chemistry utilized in this
approach is limited to glycosylated proteins and requires glycoprotein oxidation, which
may disrupt some ligand-receptor interactions and are likely not compatible with in vivo
studies. Despite these limitations, spontaneous ligand-receptor capture approaches have
demonstrated effectiveness in identifying novel interactions, and are likely to continue to be
powerful tools for identifying peptide receptors in future studies.
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Protein capture-based methods have several distinct advantages over alternative approaches
for the identification of receptors for ligands of interest. Most notably, these approaches
are fairly unbiased in the types of proteins they can hit; one generally does not need to
preselect receptor classes of interest beforehand. The unbiased nature of chemical capture
allows the discovery of unexpected interactions with a wide variety of different protein
classes. For proximity-driven ligation approaches, the spontaneous reaction between the
ligand and receptor may prove advantageous to minimize off-target interactions, simplify
MS data analysis, and build more productive crosslinks relative to more highly reactive
groups.123 However, all capture-based approaches suffer from a high potential for false
positive hits, and careful experimental controls are required to delineate true ligand-receptor
interactions from non-specific hits. Even with these essential controls, protein binders
identified using capture-based approaches may not always represent biologically interesting
interactions that account for a peptide’s bioactivity. Follow-up studies to investigate the
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physiological relevance of interactions identified in this way are critical to drawing
meaningful conclusions.

Challenges and concluding remarks

Author Manuscript

Recent methodological advancements, including those outlined above, have directly led
to the discovery of new ligand-receptor interactions, opening the doors for future studies
to explore these ligand-receptor interactions in physiology and disease. However, for a
researcher aiming to identify new peptide-receptor interactions, challenges remain. For one,
MS-based peptidomics experiments often identify hundreds of peptides within a given
tissue. Even for a given peptide, multiple forms (e.g., with different post-translational
modifications) often exist. With all of these peptides present, how does one choose the most
promising sequences to pursue for receptor identification? For these situations, the high
throughput methods above may be the best choice, although these methods have drawbacks,
particularly in having to choose a given receptor subclass and signal output to monitor for
activation.
For all approaches discussed, false positive or false negative hits can occur, and experimental
design must be carefully considered to minimize false hits. Even with the appropriate
controls, identification of a ligand-receptor pair should include rigorous validation
experiments, preferably recapitulation of activity in a recombinant system. Perhaps most
critically, identifying a putative peptide-receptor pair using many of the above methods does
not permit one to draw definitive conclusions on the function of this pair in vivo. Extensive
follow-up experiments often must be performed to assess the contributions of the identified
interaction in normal physiology and disease.
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To fully uncover the molecular mechanisms underlying peptide signaling, future efforts to
identify receptors would benefit from an “unbiased” approach that does not pre-select a
subset of receptors or signal outputs to investigate. Chemical capture-based approaches excel
in this regard, although current methods still have limitations in the types of functionalities
they can label, which may limit their general application. Unbiased chemical capture
approaches also have the advantage of being able to identify non-traditional modes of
peptide-protein interactions, such as natural peptides that engage in allosteric or antagonistic
interactions, peptides that participate in multiprotein complexes, or peptides that act as
enzyme inhibitors.16, 74 Powerful methods to rigorously identify the protein interactions
for specific peptides of interest should enable a more thorough understanding of cell-to
cell signaling in both normal physiology and disease, which may directly identify novel
therapeutic targets.
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Keywords
Peptide

A biopolymer comprised of amino acid residues.
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Neuropeptide

An endogenous signaling peptide produced and secreted by
neurons.

Peptide hormone

An endogenous signaling peptide produced and secreted
by cells other than neurons (e.g., from endocrine cells).
The same peptide sequence can be produced by multiple
different cell types, and thus can be both a neuropeptide
and a peptide hormone.

Receptor

A protein that recognizes and responds to a specific
compound or an alternative stimulus. Compounds that
bind to receptors are termed ligands. Upon ligand binding,
receptors may initiate downstream signaling events.

Cell-cell signaling

Communication between two or more cells, often through
the release of signaling molecules by one cell to activate
receptor proteins on another cell.

Peptidomics

Methods that aim to comprehensively analyze the peptide
content of a given biological sample, usually using mass
spectrometry-based methods.

GPCR

Abbreviation for G protein-coupled receptor, a large family
of membrane-embedded signaling proteins characterized
by seven transmembrane helices and their association with
heterotrimeric G proteins.

Orphan ligand

A bioactive molecule (or suspected bioactive molecule)
without an established receptor.

Orphan receptor

A receptor protein without an established ligand.

References

Author Manuscript

1. Nillni EA, Xie W, Mulcahy L, Sanchez VC, and Wetsel WC (2002) Deficiencies in pro-thyrotropin
releasing hormone processing and abnormalities in thermoregulation in Cpefat/fat mice, J. Biol.
Chem 277, 48587–48595. [PubMed: 12270926]
2. Szentirmai E, Kapas L, Sun Y, Smith RG, and Krueger JM (2009) The preproghrelin gene is
required for the normal integration of thermoregulation and sleep in mice, Proc. Natl. Acad. Sci. U.
S. A 106, 14069–14074. [PubMed: 19666521]
3. Morton GJ, Cummings DE, Baskin DG, Barsh GS, and Schwartz MW (2006) Central nervous
system control of food intake and body weight, Nature 443, 289–295. [PubMed: 16988703]
4. Atkins N Jr., Ren S, Hatcher N, Burgoon PW, Mitchell JW, Sweedler JV, and Gillette MU (2018)
Functional peptidomics: stimulus- and time-of-day-specific peptide release in the mammalian
circadian clock, ACS Chem. Neurosci 9, 2001–2008. [PubMed: 29901982]
5. Jékely G, Melzer S, Beets I, Kadow ICG, Koene J, Haddad S, and Holden-Dye L (2018) The long
and the short of it - a perspective on peptidergic regulation of circuits and behaviour, J. Exp. Biol
221, jeb166710.
6. Clynen E, Swijsen A, Raijmakers M, Hoogland G, and Rigo JM (2014) Neuropeptides as targets for
the development of anticonvulsant drugs, Mol. Neurobiol 50, 626–646. [PubMed: 24705860]

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 14

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

7. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely
D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F,
Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson
EJ, Hargreaves RJ, and Rupniak NM (1998) Distinct mechanism for antidepressant activity by
blockade of central substance P receptors, Science 281, 1640–1645. [PubMed: 9733503]
8. Juhasz G, Hullam G, Eszlari N, Gonda X, Antal P, Anderson IM, Hokfelt TG, Deakin JF, and Bagdy
G (2014) Brain galanin system genes interact with life stresses in depression-related phenotypes,
Proc. Natl. Acad. Sci. U. S. A 111, E1666–E1673. [PubMed: 24706871]
9. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, and Goke B (1993) Exendin-4 is a
high potency agonist and truncated exendin-(9–39)-amide an antagonist at the glucagon-like peptide
1-(7–36)-amide receptor of insulin-secreting beta-cells, J. Biol. Chem 268, 19650–19655. [PubMed:
8396143]
10. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen
EF, Ish-Shalom S, Genant HK, Wang O, and Mitlak BH (2001) Effect of parathyroid hormone
(1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N.
Engl. J. Med 344, 1434–1441. [PubMed: 11346808]
11. Vlieghe P, Lisowski V, Martinez J, and Khrestchatisky M (2010) Synthetic therapeutic peptides:
science and market, Drug Discovery Today 15, 40–56. [PubMed: 19879957]
12. Hokfelt T, Bartfai T, and Bloom F (2003) Neuropeptides: opportunities for drug discovery, Lancet
Neurol 2, 463–472. [PubMed: 12878434]
13. Hook V, Lietz CB, Podvin S, Cajka T, and Fiehn O (2018) Diversity of neuropeptide cell-cell
signaling molecules generated by proteolytic processing revealed by neuropeptidomics mass
spectrometry, J. Am. Soc. Mass. Spectrom 29, 807–816. [PubMed: 29667161]
14. Romanova EV, and Sweedler JV (2015) Peptidomics for the discovery and characterization of
neuropeptides and hormones, Trends Pharmacol. Sci 36, 579–586. [PubMed: 26143240]
15. Fricker LD, Lim J, Pan H, and Che FY (2006) Peptidomics: identification and quantification
of endogenous peptides in neuroendocrine tissues, Mass Spectrom. Rev 25, 327–344. [PubMed:
16404746]
16. Fricker LD, and Devi LA (2018) Orphan neuropeptides and receptors: Novel therapeutic targets,
Pharmacol. Ther 185, 26–33. [PubMed: 29174650]
17. Strowski MZ, Kaczmarek P, Mergler S, Wiedenmann B, Domin D, Szwajkowski P, Wojciechowicz
T, Skrzypski M, Szczepankiewicz D, Szkudelski T, Rucinski M, Malendowicz LK, and Nowak
KW (2009) Insulinostatic activity of cerebellin-evidence from in vivo and in vitro studies in rats,
Regul. Pept 157, 19–24. [PubMed: 19481574]
18. Gardiner JV, Beale KE, Roy D, Boughton CK, Bataveljic A, Campbell DC, Bewick GA, Patel NA,
Patterson M, Leavy EM, Ghatei MA, Bloom SR, and Dhillo WS (2010) Cerebellin1 is a novel
orexigenic peptide, Diabetes Obes. Metab 12, 883–890. [PubMed: 20920041]
19. Su J, Sandor K, Skold K, Hokfelt T, Svensson CI, and Kultima K (2014) Identification and
quantification of neuropeptides in naive mouse spinal cord using mass spectrometry reveals [des
Ser1]-cerebellin as a novel modulator of nociception, J. Neurochem 130, 199–214. [PubMed:
24749662]
20. Couso JP, and Patraquim P (2017) Classification and function of small open reading frames, Nat.
Rev. Mol. Cell Biol 18, 575–589. [PubMed: 28698598]
21. Martinez TF, Chu Q, Donaldson C, Tan D, Shokhirev MN, and Saghatelian A (2020) Accurate
annotation of human protein-coding small open reading frames, Nat. Chem. Biol 16, 458–468.
[PubMed: 31819274]
22. Santos-Alvarez J, and Sanchez-Margalet V (1998) Pancreastatin activates beta3 isoform of
phospholipase C via G(alpha)11 protein stimulation in rat liver membranes, Mol. Cell. Endocrinol
143, 101–106. [PubMed: 9806354]
23. Whiting L, Stewart KW, Hay DL, Harris PW, Choong YS, Phillips AR, Brimble MA, and Cooper
GJ (2015) Glicentin-related pancreatic polypeptide inhibits glucose-stimulated insulin secretion
from the isolated pancreas of adult male rats, Physiol. Rep 3, e12638. [PubMed: 26634904]
24. Liston D, and Rossier J (1984) Synenkephalin is coreleased with Met-enkephalin from neuronal
terminals in vitro, Neurosci. Lett 48, 211–216. [PubMed: 6548302]

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 15

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

25. Perez Sirkin DI, Lafont AG, Kamech N, Somoza GM, Vissio PG, and Dufour S (2017)
Conservation of three-dimensional helix-loop-helix structure through the vertebrate lineage
reopens the cold case of gonadotropin-releasing hormone-associated peptide, Front. Endocrinol
8, 207.
26. Bicknell AB (2016) N-terminal POMC peptides and adrenal growth, J. Mol. Endocrinol 56, T39–
T48. [PubMed: 26759392]
27. Rogge G, Jones D, Hubert GW, Lin Y, and Kuhar MJ (2008) CART peptides: regulators of body
weight, reward and other functions, Nat. Rev. Neurosci 9, 747–758. [PubMed: 18802445]
28. Laschet C, Dupuis N, and Hanson J (2018) The G protein-coupled receptors deorphanization
landscape, Biochem. Pharmacol 153, 62–74. [PubMed: 29454621]
29. Seidah NG (2011) The proprotein convertases, 20 years later, Methods Mol. Biol 768, 23–57.
[PubMed: 21805237]
30. Seidah NG, and Prat A (2012) The biology and therapeutic targeting of the proprotein convertases,
Nat. Rev. Drug Discov 11, 367–383. [PubMed: 22679642]
31. Che FY, Yan L, Li H, Mzhavia N, Devi LA, and Fricker LD (2001) Identification of peptides from
brain and pituitary of Cpefat/Cpefat mice, Proc. Natl. Acad. Sci. U. S. A 98, 9971–9976. [PubMed:
11481435]
32. Fricker LD, Evans CJ, Esch FS, and Herbert E (1986) Cloning and sequence analysis of cDNA for
bovine carboxypeptidase E, Nature 323, 461–464. [PubMed: 3020433]
33. Breslin MB, Lindberg I, Benjannet S, Mathis JP, Lazure C, and Seidah NG (1993) Differential
processing of proenkephalin by prohormone convertases 1(3) and 2 and furin, J. Biol. Chem 268,
27084–27093. [PubMed: 8262946]
34. Wardman JH, and Fricker LD (2014) ProSAAS-derived peptides are differentially processed and
sorted in mouse brain and AtT-20 cells, PLoS One 9, e104232. [PubMed: 25148519]
35. Posner SF, Vaslet CA, Jurofcik M, Lee A, Seidah NG, and Nillni EA (2004) Stepwise
posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide
by furin and PC1, Endocrine 23, 199–213. [PubMed: 15146101]
36. Song L, and Fricker LD (1995) Purification and characterization of carboxypeptidase D, a
novel carboxypeptidase E-like enzyme, from bovine pituitary, J. Biol. Chem 270, 25007–25013.
[PubMed: 7559630]
37. Funkelstein L, Lu WD, Koch B, Mosier C, Toneff T, Taupenot L, O’Connor DT, Reinheckel T,
Peters C, and Hook V (2012) Human cathepsin V protease participates in production of enkephalin
and NPY neuropeptide neurotransmitters, J. Biol. Chem 287, 15232–15241. [PubMed: 22393040]
38. Lu WD, Funkelstein L, Toneff T, Reinheckel T, Peters C, and Hook V (2012) Cathepsin H
functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin
peptide neurotransmitters, J. Neurochem 122, 512–522. [PubMed: 22582844]
39. Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Toneff T, Bundey R, Miller R, Schilling B,
Petermann I, Dehnert J, Logvinova A, Goldsmith P, Neveu JM, Lane WS, Gibson B, Reinheckel
T, Peters C, Bogyo M, and Hook V (2003) Cathepsin L in secretory vesicles functions as a
prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter, Proc.
Natl. Acad. Sci. U. S. A 100, 9590–9595. [PubMed: 12869695]
40. Eipper BA, Stoffers DA, and Mains RE (1992) The biosynthesis of neuropeptides: peptide alpha
amidation, Annu. Rev. Neurosci 15, 57–85. [PubMed: 1575450]
41. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, and Kangawa K (1999) Ghrelin is
a growth-hormone-releasing acylated peptide from stomach, Nature 402, 656–660. [PubMed:
10604470]
42. Cawley NX, Li Z, and Loh YP (2016) Biosynthesis, trafficking, and secretion of pro
opiomelanocortin-derived peptides, J. Mol. Endocrinol 56, T77–T97. [PubMed: 26880796]
43. Varro A, Henry J, Vaillant C, and Dockray GJ (1994) Discrimination between temperature- and
brefeldin A-sensitive steps in the sulfation, phosphorylation, and cleavage of progastrin and its
derivatives, J. Biol. Chem 269, 20764–20770. [PubMed: 8051178]
44. Gregory H, Hardy PM, Jones DS, Kenner GW, and Sheppard RC (1964) The antral hormone
gastrin, Nature 204, 931–933. [PubMed: 14248711]

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 16

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

45. Dockray GJ, Gregory RA, Hutchison JB, Harris JI, and Runswick MJ (1978) Isolation, structure
and biological activity of two cholecystokinin octapeptides from sheep brain, Nature 274, 711–
713. [PubMed: 79141]
46. Seidah NG, Rochemont J, Hamelin J, Lis M, and Chrétien M (1981) Primary structure of the major
human pituitary pro-opiomelanocortin NH2-terminal glycopeptide. Evidence for an aldosterone
stimulating activity, J. Biol. Chem 256, 7977–7984. [PubMed: 6267033]
47. Jakubowski JA, Hatcher NG, Xie F, and Sweedler JV (2006) The first gamma-carboxyglutamate
containing neuropeptide, Neurochem. Int 49, 223–229. [PubMed: 16522341]
48. Richter K, Egger R, and Kreil G (1987) D-Alanine in the frog skin peptide dermorphin is derived
from L-alanine in the precursor, Science 238, 200–202. [PubMed: 3659910]
49. Garden RW, Moroz TP, Gleeson JM, Floyd PD, Li L, Rubakhin SS, and Sweedler JV (1999)
Formation of N-pyroglutamyl peptides from N-Glu and N-Gln precursors in Aplysia neurons, J.
Neurochem 72, 676–681. [PubMed: 9930740]
50. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen
BJ, and Leiter EH (1995) Hyperproinsulinaemia in obese fat/fat mice associated with a
carboxypeptidase E mutation which reduces enzyme activity, Nat. Genet 10, 135–142. [PubMed:
7663508]
51. Zhu X, Zhou A, Dey A, Norrbom C, Carroll R, Zhang C, Laurent V, Lindberg I, Ugleholdt R,
Holst JJ, and Steiner DF (2002) Disruption of PC1/3 expression in mice causes dwarfism and
multiple neuroendocrine peptide processing defects, Proc. Natl. Acad. Sci. U. S. A 99, 10293–
10298. [PubMed: 12145326]
52. Saito A, Sankaran H, Goldfine ID, and Williams JA (1980) Cholecystokinin receptors in the brain:
characterization and distribution, Science 208, 1155–1156. [PubMed: 6246582]
53. Checco JW, Zhang G, Yuan WD, Yu K, Yin SY, Roberts-Galbraith RH, Yau PM, Romanova EV,
Jing J, and Sweedler JV (2018) Molecular and physiological characterization of a receptor for
D-amino acid-containing neuropeptides, ACS Chem. Biol 13, 1343–1352. [PubMed: 29543428]
54. Bicknell AB (2008) The tissue-specific processing of pro-opiomelanocortin, J. Neuroendocrinol
20, 692–699. [PubMed: 18601691]
55. Sandoval DA, and D’Alessio DA (2015) Physiology of proglucagon peptides: role of glucagon and
GLP-1 in health and disease, Physiol. Rev 95, 513–548. [PubMed: 25834231]
56. Nyberg F, Sanderson K, and Glämsta EL (1997) The hemorphins: a new class of opioid peptides
derived from the blood protein hemoglobin, Biopolymers 43, 147–156. [PubMed: 9216251]
57. Heimann AS, Gomes I, Dale CS, Pagano RL, Gupta A, de Souza LL, Luchessi AD, Castro LM,
Giorgi R, Rioli V, Ferro ES, and Devi LA (2007) Hemopressin is an inverse agonist of CB1
cannabinoid receptors, Proc. Natl. Acad. Sci. U. S. A 104, 20588–20593. [PubMed: 18077343]
58. Pauli A, Norris ML, Valen E, Chew GL, Gagnon JA, Zimmerman S, Mitchell A, Ma J, Dubrulle J,
Reyon D, Tsai SQ, Joung JK, Saghatelian A, and Schier AF (2014) Toddler: an embryonic signal
that promotes cell movement via Apelin receptors, Science 343, 1248636. [PubMed: 24407481]
59. Ma B, Zhang K, Hendrie C, Liang C, Li M, Doherty-Kirby A, and Lajoie G (2003) PEAKS:
powerful software for peptide de novo sequencing by tandem mass spectrometry, Rapid Commun.
Mass Spectrom 17, 2337–2342. [PubMed: 14558135]
60. Zhang J, Xin L, Shan B, Chen W, Xie M, Yuen D, Zhang W, Zhang Z, Lajoie GA, and Ma B
(2012) PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide
identification, Mol. Cell. Proteomics 11, M111.010587.
61. Secher A, Kelstrup CD, Conde-Frieboes KW, Pyke C, Raun K, Wulff BS, and Olsen JV
(2016) Analytic framework for peptidomics applied to large-scale neuropeptide identification, Nat.
Commun 7, 11436. [PubMed: 27142507]
62. Zhang X, Che FY, Berezniuk I, Sonmez K, Toll L, and Fricker LD (2008) Peptidomics of Cpefat/fat
mouse brain regions: implications for neuropeptide processing, J. Neurochem 107, 1596–1613.
[PubMed: 19014391]
63. Hatcher NG, Atkins N Jr., Annangudi SP, Forbes AJ, Kelleher NL, Gillette MU, and Sweedler JV
(2008) Mass spectrometry-based discovery of circadian peptides, Proc. Natl. Acad. Sci. U. S. A
105, 12527–12532. [PubMed: 18719122]

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 17

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

64. Haskins WE, Watson CJ, Cellar NA, Powell DH, and Kennedy RT (2004) Discovery and
neurochemical screening of peptides in brain extracellular fluid by chemical analysis of in vivo
microdialysis samples, Anal. Chem 76, 5523–5533. [PubMed: 15362916]
65. Jansson ET, Comi TJ, Rubakhin SS, and Sweedler JV (2016) Single cell peptide heterogeneity of
rat islets of Langerhans, ACS Chem. Biol 11, 2588–2595. [PubMed: 27414158]
66. Neupert S (2018) Single cell peptidomics: approach for peptide identification by N-terminal
peptide derivatization, Methods Mol. Biol 1719, 369–378. [PubMed: 29476525]
67. Rubakhin SS, Garden RW, Fuller RR, and Sweedler JV (2000) Measuring the peptides in
individual organelles with mass spectrometry, Nat. Biotechnol 18, 172–175. [PubMed: 10657123]
68. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, and Morris HR (1975)
Identification of two related pentapeptides from the brain with potent opiate agonist activity,
Nature 258, 577–580. [PubMed: 1207728]
69. Lembo PM, Grazzini E, Groblewski T, O’Donnell D, Roy MO, Zhang J, Hoffert C, Cao J, Schmidt
R, Pelletier M, Labarre M, Gosselin M, Fortin Y, Banville D, Shen SH, Strom P, Payza K, Dray A,
Walker P, and Ahmad S (2002) Proenkephalin A gene products activate a new family of sensory
neuron-specific GPCRs, Nat. Neurosci 5, 201–209. [PubMed: 11850634]
70. Guan Y, Liu Q, Tang Z, Raja SN, Anderson DJ, and Dong X (2010) Mas-related G-protein-coupled
receptors inhibit pathological pain in mice, Proc. Natl. Acad. Sci. U. S. A 107, 15933–15938.
[PubMed: 20724664]
71. Li Z, Tseng PY, Tiwari V, Xu Q, He SQ, Wang Y, Zheng Q, Han L, Wu Z, Blobaum AL, Cui Y,
Tiwari V, Sun S, Cheng Y, Huang-Lionnet JH, Geng Y, Xiao B, Peng J, Hopkins C, Raja SN, Guan
Y, and Dong X (2017) Targeting human Mas-related G protein-coupled receptor X1 to inhibit
persistent pain, Proc. Natl. Acad. Sci. U. S. A 114, E1996–E2005. [PubMed: 28223516]
72. Breit A, Gagnidze K, Devi LA, Lagacé M, and Bouvier M (2006) Simultaneous activation of
the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer
by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits
deltaOR signaling, Mol. Pharmacol 70, 686–696. [PubMed: 16682504]
73. Steiner DF, Hallund O, Rubenstein A, Cho S, and Bayliss C (1968) Isolation and properties
of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin,
Diabetes 17, 725–736. [PubMed: 5726253]
74. Wisner A, Dufour E, Messaoudi M, Nejdi A, Marcel A, Ungeheuer MN, and Rougeot C (2006)
Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways, Proc. Natl.
Acad. Sci. U. S. A 103, 17979–17984. [PubMed: 17101991]
75. Foster SR, Hauser AS, Vedel L, Strachan RT, Huang XP, Gavin AC, Shah SD, Nayak AP,
Haugaard-Kedström LM, Penn RB, Roth BL, Bräuner-Osborne H, and Gloriam DE (2019)
Discovery of human signaling systems: pairing peptides to G protein-coupled receptors, Cell 179,
895–908. [PubMed: 31675498]
76. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA, and Hsueh AJ (2003) H3 relaxin
is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain
and the exoloop 2, J. Biol. Chem 278, 7855–7862. [PubMed: 12506116]
77. Liu C, Chen J, Sutton S, Roland B, Kuei C, Farmer N, Sillard R, and Lovenberg TW (2003)
Identification of relaxin-3/INSL7 as a ligand for GPCR142, J. Biol. Chem 278, 50765–50770.
[PubMed: 14522967]
78. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, Farmer N, Jörnvall H, Sillard R, and
Lovenberg TW (2003) Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan
G-protein-coupled receptor GPCR135, J. Biol. Chem 278, 50754–50764. [PubMed: 14522968]
79. Chavkin C, James IF, and Goldstein A (1982) Dynorphin is a specific endogenous ligand of the
kappa opioid receptor, Science 215, 413–415. [PubMed: 6120570]
80. Fricker LD, Margolis EB, Gomes I, and Devi LA (2020) Five decades of research on opioid
peptides: current knowledge and unanswered questions, Mol. Pharmacol 98, 96–108. [PubMed:
32487735]
81. Meyrath M, Szpakowska M, Zeiner J, Massotte L, Merz MP, Benkel T, Simon K, Ohnmacht
J, Turner JD, Krüger R, Seutin V, Ollert M, Kostenis E, and Chevigné A (2020) The atypical

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 18

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides, Nat.
Commun 11, 3033. [PubMed: 32561830]
82. Ikeda Y, Kumagai H, Skach A, Sato M, and Yanagisawa M (2013) Modulation of circadian
glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior, Cell 155,
1323–1336. [PubMed: 24315101]
83. Cheloha RW, Gellman SH, Vilardaga JP, and Gardella TJ (2015) PTH receptor-1 signalling
mechanistic insights and therapeutic prospects, Nat. Rev. Endocrinol 11, 712–724. [PubMed:
26303600]
84. Kim YJ, Bartalska K, Audsley N, Yamanaka N, Yapici N, Lee JY, Kim YC, Markovic M, Isaac
E, Tanaka Y, and Dickson BJ (2010) MIPs are ancestral ligands for the sex peptide receptor, Proc.
Natl. Acad. Sci. U. S. A 107, 6520–6525. [PubMed: 20308537]
85. Borg CB, Braun N, Heusser SA, Bay Y, Weis D, Galleano I, Lund C, Tian W, Haugaard-Kedström
LM, Bennett EP, Lynagh T, Strømgaard K, Andersen J, and Pless SA (2020) Mechanism and site
of action of big dynorphin on ASIC1a, Proc. Natl. Acad. Sci. U. S. A 117, 7447–7454. [PubMed:
32165542]
86. Chen L, Gu Y, and Huang LY (1995) The opioid peptide dynorphin directly blocks NMDA
receptor channels in the rat, J. Physiol 482, 575–581. [PubMed: 7537820]
87. Schmidt A, Bauknecht P, Williams EA, Augustinowski K, Grunder S, and Jékely G (2018) Dual
signaling of Wamide myoinhibitory peptides through a peptide-gated channel and a GPCR in
Platynereis, FASEB J 32, 5338–5349. [PubMed: 29688813]
88. Osmakov DI, Koshelev SG, Ivanov IA, Andreev YA, and Kozlov SA (2019) Endogenous
neuropeptide nocistatin is a direct agonist of acid-sensing ion channels (ASIC1, ASIC2 and
ASIC3), Biomolecules 9, 401.
89. Lingueglia E, Champigny G, Lazdunski M, and Barbry P (1995) Cloning of the amiloride-sensitive
FMRFamide peptide-gated sodium channel, Nature 378, 730–733. [PubMed: 7501021]
90. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao
YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, and Ramachandran J (1985)
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes, Nature
313, 756–761. [PubMed: 2983222]
91. Potter LR, Abbey-Hosch S, and Dickey DM (2006) Natriuretic peptides, their receptors, and cyclic
guanosine monophosphate-dependent signaling functions, Endocr. Rev 27, 47–72. [PubMed:
16291870]
92. Chang JC, Yang RB, Adams ME, and Lu KH (2009) Receptor guanylyl cyclases in Inka cells
targeted by eclosion hormone, Proc. Natl. Acad. Sci. U. S. A 106, 13371–13376. [PubMed:
19666575]
93. Bole-Feysot C, Goffin V, Edery M, Binart N, and Kelly PA (1998) Prolactin (PRL) and its receptor:
actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice,
Endocr. Rev 19, 225–268. [PubMed: 9626554]
94. Friedman JM, and Halaas JL (1998) Leptin and the regulation of body weight in mammals, Nature
395, 763–770. [PubMed: 9796811]
95. Haruta M, Sabat G, Stecker K, Minkoff BB, and Sussman MR (2014) A peptide hormone and its
receptor protein kinase regulate plant cell expansion, Science 343, 408–411. [PubMed: 24458638]
96. Gomes I, Aryal DK, Wardman JH, Gupta A, Gagnidze K, Rodriguiz RM, Kumar S, Wetsel WC,
Pintar JE, Fricker LD, and Devi LA (2013) GPR171 is a hypothalamic G protein-coupled receptor
for BigLEN, a neuropeptide involved in feeding, Proc. Natl. Acad. Sci. U. S. A 110, 16211–16216.
[PubMed: 24043826]
97. Gomes I, Bobeck EN, Margolis EB, Gupta A, Sierra S, Fakira AK, Fujita W, Muller TD, Muller A,
Tschop MH, Kleinau G, Fricker LD, and Devi LA (2016) Identification of GPR83 as the receptor
for the neuroendocrine peptide PEN, Sci. Signal 9, ra43. [PubMed: 27117253]
98. Quiroga Artigas G, Lapébie P, Leclère L, Bauknecht P, Uveira J, Chevalier S, Jékely G, Momose
T, and Houliston E (2020) A G protein–coupled receptor mediates neuropeptide-induced oocyte
maturation in the jellyfish Clytia, PLOS Biology 18, e3000614. [PubMed: 32126082]

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 19

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

99. Yosten GL, Redlinger LJ, and Samson WK (2012) Evidence for an interaction of neuronostatin
with the orphan G protein-coupled receptor, GPR107, Am. J. Physiol. Regul. Integr. Comp.
Physiol 303, R941–R949. [PubMed: 22933024]
100. Yosten GL, Kolar GR, Redlinger LJ, and Samson WK (2013) Evidence for an interaction between
proinsulin C-peptide and GPR146, J. Endocrinol 218, B1–B8.
101. Stein LM, Tullock CW, Mathews SK, Garcia-Galiano D, Elias CF, Samson WK, and Yosten GL
(2016) Hypothalamic action of phoenixin to control reproductive hormone secretion in females:
importance of the orphan G protein-coupled receptor Gpr173, Am. J. Physiol. Regul. Integr.
Comp. Physiol 311, R489–R496. [PubMed: 27440717]
102. Stein LM, Yosten GL, and Samson WK (2016) Adropin acts in brain to inhibit water drinking:
potential interaction with the orphan G protein-coupled receptor, GPR19, Am. J. Physiol. Regul.
Integr. Comp. Physiol 310, R476–R480. [PubMed: 26739651]
103. Yosten GL, Harada CM, Haddock C, Giancotti LA, Kolar GR, Patel R, Guo C, Chen Z, Zhang
J, Doyle TM, Dickenson AH, Samson WK, and Salvemini D (2020) GPR160 de-orphanization
reveals critical roles in neuropathic pain in rodents, J. Clin. Invest 130, 2587–2592. [PubMed:
31999650]
104. Rao A, and Herr DR (2017) G protein-coupled receptor GPR19 regulates E-cadherin expression
and invasion of breast cancer cells, Biochim. Biophys. Acta, Mol. Cell Res 1864, 1318–1327.
[PubMed: 28476646]
105. Elrick MM, Samson WK, Corbett JA, Salvatori AS, Stein LM, Kolar GR, Naatz A, and Yosten
GL (2016) Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation
and proglucagon mRNA accumulation in pancreatic α-cells, Am. J. Physiol. Regul. Integr.
Comp. Physiol 310, R143–R155. [PubMed: 26561648]
106. Kroeze WK, Sassano MF, Huang XP, Lansu K, McCorvy JD, Giguère PM, Sciaky N, and Roth
BL (2015) PRESTO-Tango as an open-source resource for interrogation of the druggable human
GPCRome, Nat. Struct. Mol. Biol 22, 362–369. [PubMed: 25895059]
107. Hay DL, and Pioszak AA (2016) Receptor Activity-Modifying Proteins (RAMPs): New Insights
and Roles, Annu. Rev. Pharmacol. Toxicol 56, 469–487. [PubMed: 26514202]
108. Wood L, and Wright GJ (2019) Approaches to identify extracellular receptor-ligand interactions,
Curr. Opin. Struct. Biol 56, 28–36. [PubMed: 30469141]
109. Sharma S, Bartholdson SJ, Couch ACM, Yusa K, and Wright GJ (2018) Genome-scale
identification of cellular pathways required for cell surface recognition, Genome Res 28, 1372–
1382. [PubMed: 29914970]
110. Bauknecht P, and Jékely G (2015) Large-scale combinatorial deorphanization of Platynereis
neuropeptide GPCRs, Cell Rep 12, 684–693. [PubMed: 26190115]
111. Jékely G (2013) Global view of the evolution and diversity of metazoan neuropeptide signaling,
Proc. Natl. Acad. Sci. U. S. A 110, 8702–8707. [PubMed: 23637342]
112. Bao C, Yang Y, Zeng C, Huang H, and Ye H (2018) Identifying neuropeptide GPCRs in the mud
crab, Scylla paramamosain, by combinatorial bioinformatics analysis, Gen. Comp. Endocrinol
269, 122–130. [PubMed: 30189191]
113. Thiel D, Bauknecht P, Jékely G, and Hejnol A (2017) An ancient FMRFamide-related peptide
receptor pair induces defence behaviour in a brachiopod larva, Open Biol 7, 170136. [PubMed:
28835571]
114. Shiraishi A, Okuda T, Miyasaka N, Osugi T, Okuno Y, Inoue J, and Satake H (2019) Repertoires
of G protein-coupled receptors for Ciona-specific neuropeptides, Proc. Natl. Acad. Sci. U. S. A
116, 7847–7856. [PubMed: 30936317]
115. Hoffmann C, Castro M, Rinken A, Leurs R, Hill SJ, and Vischer HF (2015) Ligand residence
time at G-protein-coupled receptors-why we should take our time to study it, Mol. Pharmacol 88,
552–560. [PubMed: 26152198]
116. Couvineau A, and Laburthe M (1985) The human vasoactive intestinal peptide receptor:
molecular identification by covalent cross-linking in colonic epithelium, J. Clin. Endocrinol.
Metab 61, 50–55. [PubMed: 2987295]

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 20

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

117. Chatterjee TK, Moy JA, Cai JJ, Lee HC, and Fisher RA (1993) Solubilization and
characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide
receptor, Mol. Pharmacol 43, 167–175. [PubMed: 8381507]
118. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, and Li Y (1996) A cDNA
encoding the calcitonin gene-related peptide type 1 receptor, J. Biol. Chem 271, 11325–11329.
[PubMed: 8626685]
119. Yamaguchi Y, Pearce G, and Ryan CA (2006) The cell surface leucine-rich repeat receptor for
AtPep1, an endogenous peptide elicitor in Arabidopsis, is functional in transgenic tobacco cells,
Proc. Natl. Acad. Sci. U. S. A 103, 10104–10109. [PubMed: 16785433]
120. Müskens FM, Ward RJ, Herkt D, van de Langemheen H, Tobin AB, Liskamp RMJ, and Milligan
G (2019) Design, synthesis, and evaluation of a diazirine photoaffinity probe for ligand-based
receptor capture targeting G protein-coupled receptors, Mol. Pharmacol 95, 196–209. [PubMed:
30514721]
121. Kleiner P, Heydenreuter W, Stahl M, Korotkov VS, and Sieber SA (2017) A whole proteome
inventory of background photocrosslinker binding, Angew. Chem. Int. Ed 56, 1396–1401.
122. Tanaka Y, Bond MR, and Kohler JJ (2008) Photocrosslinkers illuminate interactions in living
cells, Mol. BioSyst 4, 473–480. [PubMed: 18493640]
123. Yang B, Tang S, Ma C, Li ST, Shao GC, Dang B, DeGrado WF, Dong MQ, Wang PG, Ding S,
and Wang L (2017) Spontaneous and specific chemical cross-linking in live cells to capture and
identify protein interactions, Nat. Commun 8, 2240. [PubMed: 29269770]
124. Tamura T, and Hamachi I (2019) Chemistry for covalent modification of endogenous/native
proteins: from test tubes to complex biological systems, J. Am. Chem. Soc 141, 2782–2799.
[PubMed: 30592612]
125. Frei AP, Jeon OY, Kilcher S, Moest H, Henning LM, Jost C, Plückthun A, Mercer J, Aebersold
R, Carreira EM, and Wollscheid B (2012) Direct identification of ligand-receptor interactions on
living cells and tissues, Nat. Biotechnol 30, 997–1001. [PubMed: 22983091]
126. Belle NM, Ji Y, Herbine K, Wei Y, Park J, Zullo K, Hung LY, Srivatsa S, Young T, Oniskey
T, Pastore C, Nieves W, Somsouk M, and Herbert DR (2019) TFF3 interacts with LINGO2
to regulate EGFR activation for protection against colitis and gastrointestinal helminths, Nat.
Commun 10, 4408. [PubMed: 31562318]
127. Ponda MP, and Breslow JL (2016) Serum stimulation of CCR7 chemotaxis due to coagulation
factor XIIa-dependent production of high-molecular-weight kininogen domain 5, Proc. Natl.
Acad. Sci. U. S. A 113, E7059–E7068. [PubMed: 27791187]
128. Li Y, Ozment T, Wright GL, and Peterson JM (2016) Identification of putative receptors for
the novel adipokine CTRP3 using ligand-receptor capture technology, PLoS One 11, e0164593.
[PubMed: 27727322]
129. Roche FP, Pietilä I, Kaito H, Sjöström EO, Sobotzki N, Noguer O, Skare TP, Essand M,
Wollscheid B, Welsh M, and Claesson-Welsh L (2018) Leukocyte differentiation by histidine
rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation
of antitumor immunity, Mol. Cancer Ther 17, 1961–1972. [PubMed: 29945872]
130. Galoian K, Abrahamyan S, Chailyan G, Qureshi A, Patel P, Metser G, Moran A, Sahakyan I,
Tumasyan N, Lee A, Davtyan T, Chailyan S, and Galoyan A (2018) Toll like receptors TLR1/2,
TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in
human chondrosarcoma, Int. J. Oncol 52, 139–154. [PubMed: 29138803]
131. Sörensen-Zender I, Chen R, Rong S, David S, Melk A, Haller H, and Schmitt R (2019) Binding
to carboxypeptidase M mediates protective effects of fibrinopeptide Bβ15–42, Transl. Res 213,
124–135. [PubMed: 31401267]
132. Garelli A, Heredia F, Casimiro AP, Macedo A, Nunes C, Garcez M, Dias ARM, Volonte YA,
Uhlmann T, Caparros E, Koyama T, and Gontijo AM (2015) Dilp8 requires the neuronal relaxin
receptor Lgr3 to couple growth to developmental timing, Nat. Commun 6, 8732. [PubMed:
26510564]
133. Sobotzki N, Schafroth MA, Rudnicka A, Koetemann A, Marty F, Goetze S, Yamauchi Y, Carreira
EM, and Wollscheid B (2018) HATRIC-based identification of receptors for orphan ligands, Nat.
Commun 9, 1519. [PubMed: 29666374]

ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 21

Author Manuscript

134. Tremblay TL, and Hill JJ (2017) Biotin-transfer from a trifunctional crosslinker for identification
of cell surface receptors of soluble protein ligands, Sci. Rep 7, 46574. [PubMed: 28422167]

Author Manuscript
Author Manuscript
Author Manuscript
ACS Chem Biol. Author manuscript; available in PMC 2021 September 29.

Abid et al.

Page 22

Author Manuscript
Author Manuscript
Author Manuscript
Figure 1.

Author Manuscript

Biosynthesis of precursor-derived peptides involves extensive post-translational
modifications. As a result, a given precursor often generates many different mature
peptide products, and these products can differ based on tissue or physiological state.
The mature forms of these peptides often cannot be predicted from genomic or
transcriptomic information. PCs, prohormone convertases. CPE, carboxypeptidase E. PTMs,
post-translational modifications.
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Figure 2.

Endogenous peptide-receptor interactions are often more complex than a one peptide-one
receptor model. Shown is a cartoon representation showing types of peptide-receptor
dynamics common for known neuropeptide and peptide hormone systems.
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Cartoon depiction of some possible receptors for a given bioactive peptide of interest.
Peptides can signal through receptors that are not orphan GPCRs. Receptor identification
studies may benefit from fully exploring these possibilities.
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Figure 4.

Identifying peptide receptors based on tissue expression. First, cell lines or tissues are
identified that show biological response to the peptide of interest. Then, receptor transcripts
(typically for orphan GPCRs only) are compared among the identified tissues to identify
receptors candidates. A select number of candidate receptors are chosen for direct evaluation
in recombinant receptor activation assays.
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Identifying peptide receptors using high-throughput screening. A variety of methods can
be used to identify a library of putative neuropeptides and a library of putative receptors.
Putative neuropeptides are chemically synthesized, and cell lines expressing each putative
receptor are generated. Following this, each candidate receptor is screened against each
of the candidate peptides (or pools of peptides) and downstream signaling is measured to
identify hits. Putative ligand-receptor pairs can then be validated in subsequent cell-based
assays.
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Identifying receptors using chemical capture.125, 133 In this example, cells natively
expressing glycoproteins are treated with oxidant to generate reactive aldehyde
functionalities. These chemically modified cells are then treated with ligand analogue
bearing an aldehyde-reactive functionality and a handle for enrichment (e.g., azide, alkyne,
or biotin). Covalent crosslinking of ligand to receptor proteins allows for enrichment
after cell lysis and membrane solubilization, and identification of captured proteins is
accomplished through MS-based proteomics methods. The white circle in ligand analogue
structure represents variable chemical structure used to link ligand directing group,
aldehyde-reactive group, and enrichment handle.
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